Company / Working Capital
Dyne Therapeutics, Inc. Working Capital History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$617.0M
FY2024
5-year range
$78.3M / $617.0M
FY2020-FY2024
Trend
+688.2%
vs FY2023
Sector context
#74 of 215
Health Care
What the data says
Working Capital changed +688% YoY in FY2024, a notable deviation from the 5-year average annual change of +644%.
Based on SEC 10-K filings.
$617M in FY2024 with a 5-year CAGR of +118.5%.
Improved from $238M to $617M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +20.4%
- 5-Year CAGR
- +118.5%
- 10-Year CAGR
- -
Sector benchmark
#74 of 215 in Health CareTop 34% of 215This company $617.0M Sector average $957.8M
▼
-35.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +118.5%, indicating consistent growth.
- In FY2024, working capital increased 688.2% year-over-year.
- Ranks #74 out of 215 companies in the Health Care sector.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $617.0M | +688.2% |
| FY2023 | $78.3M | -67.0% |
| FY2022 | $237.5M | -32.8% |
| FY2021 | $353.7M | +4.6% |
| FY2020 | $338.1M | +2626.6% |
| FY2019 | $12.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026